InvestorsHub Logo
Followers 106
Posts 10171
Boards Moderated 0
Alias Born 02/25/2003

Re: GreenKnight post# 25472

Wednesday, 10/07/2020 4:05:55 PM

Wednesday, October 07, 2020 4:05:55 PM

Post# of 44690
Yes, " Because of its lack of toxicity and low cost of manufacture compared to proprietary biologics, VIP may be uniquely attractive to those focused on global countermeasures against COVID-19."

~ Money Making Money ~